View all news

Bruker Sets New Standards in Preclinical Imaging Software with ParaVision 6

September 18, 2013

Higher Productivity, Increased Performance and Easy Access to MRI for Translational and Pharmaceutical Research

SAVANNAH, Ga.--(BUSINESS WIRE)--Sep. 18, 2013-- At the 2013 World Molecular Imaging Congress (WMIC,www.wmicmeeting.org), Bruker (NASDAQ: BRKR) today introduces itsParaVision®6software, setting new standards in preclinical MRI software that delivers significantly enhanced productivity for both, routine users and accomplished experts. A redefined workflow introduces optimized, application-oriented experimental protocols, an intuitive, interactive 3D scan planning viewport, and automatic reporting. Thanks to its DICOM-based data exchange module,ParaVision 6seamlessly integrates with data from multimodal imaging studies employed in many preclinical research labs.

Delivering a quantum leap in ease of use, the redesignedParaVision 6workflow is designed with preclinical imaging in mind, featuring a newly developed user interface and easy parameter handling. A guided imaging workflow produces consistent results and lowers the learning curve for biomedical researchers new to MRI. A context-sensitive view reduces complexity by visualizing only parameters relevant to the operations at hand, ensuring intuitive and focused operation.

ParaVision 6includes an extensive set of routine and advanced imaging sequences, supports seamless integration of parallel transmission techniques and incorporates a unique, integrated field map-based shimming procedure. Integrated, real-time optimization features enable dynamic adjustment of parameters during scanning, provide integration of navigator scans, and on-the-fly, automatically calculated Shinnar-LeRoux RF pulses for optimum slice profiles. In addition, automatic hardware recognition improves the set-up and reliability of the MRI system.

“With its innovative workflow concept,ParaVision 6opens the door for preclinical MRI technology into new labs in pharma and translational research, while at the same time significantly increasing the productivity of research MRI users who welcome automated execution routines,” stated Dr. Wulf I. Jung, President of Bruker’s Preclinical Imaging Division.

ParaVision 6is designed to benefit all modern Bruker MRI platforms fromAVANCE™ IItoAVANCE III HD, as well asICON™benchtop MRI andMPI(magnetic particle imaging) systems.AVANCE III HDsystems in particular benefit from new power management features that display the state of the system and its components, in addition to providing push-button system start-up and shutdown. TheParaVision 6true 64-bit architecture and parallel multi-core acquisition and reconstruction deliver high-resolution 3D images up to virtually unlimited size. Advanced users will welcome the fully integrated method development environment that enables them to redefine their own boundaries in imaging research.

About Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) is a leading provider of high performance scientific instruments and solutions for molecular and materials research, as well as for diagnostics, industrial, clinical and applied analysis.

For more information:www.energie2point0.com

For more information onParaVision 6:www.energie2point0.com/ParaVision.

For more information on Bruker at WMIC:www.energie2point0.com/WMIC

Source: Bruker Corporation

Bruker
Dr. Thorsten Thiel, +49 (721) 5161 – 6500
导演r of Marketing Communications
[email protected]

Categories: Press Releases
View all news